Relationship between total and lipid-bound serum sialic acid and some tumor markers

Iranian Journal of Medical Sciences

Volumn 30, Issue 3, 2005, Pages 124-127

  Goodarzi, M T ^a   Shafiei, M ^b   Nomani, H ^b   Shahriarahmadi, A ^b  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cancer; Sialic acid; Tumor markers

Indexed keywords

CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; LIPID; SIALIC ACID; TUMOR MARKER;

ADULT; ARTICLE; CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; SPECTROPHOTOMETRY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 32044436108     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Waters PJ, Lewry E, Pennock CA. Measurement of sialic acid in serum and urine: clinical applications and limitations. Ann Clin Biochem 1992; 29: 625-37.
2. Crook MA, Tutt P, Simpson H, Pickup JC. Serum sialic acid and acute phase proteins in type 1 and type 2 diabetes mellitus. Clin Chim Acta 1993; 219: 131-8.
3. Kiziltunc A, Cogalgil S, Ugur M, et al. Sialic acid, transketolase and Na+, K+, ATPase in patients with rheumatoid arthritis. Clin Chem Lab Med 1998; 36: 289-93.
4. Raval GN, Patel DD, Parekh LJ, et al. Evaluation of serum sialic acid, sialyltransferase and sialoprotein in oral cavity cancer. Oral Dis 2003; 9: 119-28.
5. Manju V, Balasubramanian V, Nalini N. Oxidative stress and tumor markers in cervical cancer patients. J Biochem Mol Biol Biophys 2002; 6: 387-90.
6. Lopez Saez JJ, Senra-Varela A. Evaluation of lipid-bound sialic acid (LASA) as a tumor marker. Int J Biol Markers 1995; 10: 174-9.
7. Romppanen J, Petaja J, Heikinheimo M, et al. Total and lipid-bound serum sialic acid in children with malignancy or infections. Anticancer Res 1998; 18: 2793-7.
8. Katopodis N, Hirshaut Y, Geller NL, et al. Lipid-associated sialic acid test for the detection of human cancer. Cancer Research 1982; 42: 5270-5.
9. Paszkowska A, Berbec H, Semczuk A, et al. Sialic acid concentration in serum and tissue of endometrial cancer patients. Eur J Obst&Gyn Repro Biol 1998; 76: 211-5.
10. Hobarth K, Hofbauer J, Fang-Kircher S. Plasma sialic acid in patients with prostate cancer. Br J Urol 1993; 72: 621-4.
11. Romppanen J, Eskelinen M, Tikanoja S. et al. Total and lipid-bound serum sialic acid in benign and malignant breast disease. Anticancer Res 1997; 1249-53.
12. Brower ST, Tartter P, Weiss S, et al. Breast cancer and family history: levels of lipid-associated sialic acid in plasma and absent family history of breast cancer in women who have tumors. Mt Sinai J Med 1995; 62: 419-21.
13. Berbec H, Paszkowska A, Siwek B, et al. Total serum sialic acid concentration as a supporting marker of malignancy in ovarian neoplasia. Eur j Gyneecol Oncol 1999; 20: 389-92.
14. Surangkul D, Pothacharoen P, Suttajit M et al. A periodate-Resorcinol microassay for the quantitation of total sialic acid in human serum. Chiang Mai Med Bull 2001; 40: 111-8.
15. Jekel JF, Katz DL, Elmore JG. Epidemiology, Biostatics, and Preventive Medicine. 2nd ed. New York, W. B. Saunders Company; 2001. p. 172-8.
16. Wongkham S, Boonla C, Kongkham S, et al. Serum total sialic acid in cholangiocarcinoma patients: an ROC curve analysis. Clin Biochem 2001; 34: 537-41.
17. Ros-Bullon MR, Sanchez-Pedreno P, Martinez-Liarte JH. Serum sialic acid in malignant melanoma patients: a ROC curve analysis. Anticancer Res 1999; 19: 3619-22.
18. Raval GN, Parekh LJ, Patel MM. et al. Role of sialic acid and alkaline DNase in breast cancer. Int J Biol Markers 1997; 12: 61-7.
19. Wongkham S, Bhudhisawasdi V, Chau-in S, et al. Clinical significance of serum total sialic acid in cholngiocarcinoma. Clin Chim Acta 2003; 327: 139-47.
20. Basoglu M, Yildirgan MI, Taysi S, et al. Levels of soluble intercellular adhesion molecule-1 and total sialic acid in serum of patients with colorectal cancer. J Surg Oncol 2003; 83: 180-4.
21. Goodarzi MT, Turner GA. Decreased branching, increased fucosylation and changed sialylation of alpha-1-proteinase inhibitor in breast and ovarian cancer. Clinical Chimica Acta 1995; 236; 161-71.
22. Goodarzi MT. Changes in glycosylation of alpha-1-protease inhibitor in inflammation (rheumatoid arthritis and Crohn's disease). Iran Biomed J 1999; 3: 23-9.
23. Goodarzi MT, Axford JS, Varanasi SS, et al. Sialyl lewis X expression on IgG Rhematoid Arthritis and other arthritic conditions: a preliminary study. Glycoconjugate Journal 1998; 15: 1149-54.
24. Kongtawelert P, Tangkijvanich P, Ong-Chai S, et al. Role of serum total sialic acid in differentiating cholangiocarcinoma from hepatocellular carcinoma. World J Gastroenterology 2003; 9: 2178-81.